ISTH/LinkedIn
Oct 3, 2025, 12:30
ISTH: Advancing Hemophilia Treatment Today and Tomorrow
International Society on Thrombosis and Haemostasis (ISTH) shared a post on LinkedIn:
“New CME opportunity! The hemophilia treatment landscape is rapidly evolving — are you up to date?
Our latest expert-led module, Updates in FVIIa Mimetics: Advancing Hemophilia Treatment Today and Tomorrow, is designed for hematology care teams including physicians, NPs, PAs, nurses and pharmacists.
What you’ll get:
- Key insights into emerging therapies
- Clinical trial updates
- Best practices to individualize patient care”
Start learning today here
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?